Background: Hidradenitis suppurativa (HS) is associated with lower socioeconomic status (SES). The adverse influence of HS on education and employment may explain this. It remains unknown whether HS causes downward social trajectories, i.e., social drift, or whether those affected are born into a lower SES. We aimed to assess the influence of HS on education and employment and compare the highest educational attainment of participants with their parents. Methods: An anonymous online survey was distributed by patient-led organisations. Frequencies were compared with χ2 and disease interactions with one-way ANOVA. Results: Among 335 respondents from 10 countries, 94.9% completed secondary/high school, 71.3% completed further education, 41.8% completed an undergraduate degree, 20% completed postgraduate education, 10.7% completed a masters, and 2.1% completed a doctorate. Participant education was greater than parental education (p < 0.001). Despite this, 24.2% were unemployed and 15.2% were receiving illness benefit. Compared to national statistics, HS participants from Ireland (p = 0.003), the USA (p < 0.001), and the UK (p < 0.001) were more likely to be unemployed/receiving illness benefit despite higher educational attainment in Ireland (p = 0.006) and the USA (p = 0.003) with similar education in the UK (p = 0.153). Conclusions: Social drift describes downward social trajectories due to the development of a disease. Participants in this study report greater education than their parents and the background population, but despite this, they are experiencing downward social trajectories with higher unemployment and receipt of illness benefit. Disease onset in HS tends to be at peak educational age. Education does not appear to be impaired by early disease with disease accumulation during employment years limiting opportunities.

1.
Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.
2.
Wertenteil S, Strunk A, Garg A. Association of low socioeconomic status with hidradenitis suppurativa in the United States. JAMA Dermatol. 2018;154(9):1086–8.
3.
Deckers IE, Janse IC, van der Zee HH, Nijsten T, Boer J, Horváth B, et al. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study. J Am Acad Dermatol. 2016;75(4):755–9.e1.
4.
Tzellos T, Yang H, Mu F, Calimlim B, Signorovitch J. Impact of hidradenitis suppurativa on work loss, indirect costs and income. Br J Dermatol. 2019;181(1):147–54.
5.
Delany E, Gormley G, Hughes R, McCarthy S, Kirthi S, Markham T, et al. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol. 2018;32(3):467–73.
6.
van Straalen KR, Prens LM, Hylkema TH, Janse IC, Dickinson J, Houwing R, et al. Impact of hidradenitis suppurativa on work productivity and associated risk factors. J Am Acad Dermatol. 2021;84(5):1401–5.
7.
Schneider-Burrus S, Kalus S, Fritz B, Wolk K, Gomis-Kleindienst S, Sabat R. The impact of hidradenitis suppurativa on professional life. Br J Dermatol. 2022;188(1):122–30.
8.
Vargas G, Strassnig M, Sabbag S, Gould F, Durand D, Stone L, et al. The course of vocational functioning in patients with schizophrenia: Re-examining social drift. Schizophr Res Cogn. 2014;1(1):e41–6.
9.
O’Donoghue B, Lyne JP, Fanning F, Kinsella A, Lane A, Turner N, et al. Social class mobility in first episode psychosis and the association with depression, hopelessness and suicidality. Schizophr Res. 2014;157(1–3):8–11.
10.
Warren RB, Kleyn CE, Gulliver WP. Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course. Br J Dermatol. 2011;164(Suppl 1):1–14.
11.
von Stülpnagel CC, Augustin M, Düpmann L, da Silva N, Sommer R. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases: a systematic review. J Eur Acad Dermatol Venereol. 2021;35(11):2166–84.
12.
USCB. S1501: educational attainment. United States Census Bureau; 2020.
13.
BLS. Civilian Unemployment rate. United States Bureau of Labor Statistics; 2022.
14.
SSA. Annual statistical report on the social security disability insurance program, 2019. Social Security Administration; 2020.
15.
CSO. Census 2016: Profile 10 – education skills and the Irish language. Central Statistics Office; 2016.
16.
CSO. Census 2016: Summary results part 1. Central Statistics Office; 2016.
17.
CSO. Labour market release archive 2022. Central Statistics Office; 2022.
18.
CSO. Illness Benefits: employment and commuting analysis 2016–2017. Central Statistics Office; 2020.
19.
Gov.uk. Highest qualification for adults aged 19–64. Education and training statistics for the UK. 2021.
20.
Gov.uk. Apprenticeships, 14 to 19 education and training for work. Education and learning.
21.
ONS. Unemployment rate (aged 16 and over, seasonally adjusted): %. Office of National Statistics; 2022.
22.
Kirk-Wade E. UK disability statistics: prevalence and life experiences. House of Commons Library; 2022.
23.
NISRA. Northern Ireland Benefits statistics summary February 2022. Professional Services Unit (Department for Communities); 2022.
24.
ONS. LFS: Unemployment rate: UK: all: aged 25–49: %: SA. Office of National Statistics; 2022.
25.
Singh-Manoux A, Adler NE, Marmot MG. Subjective social status: its determinants and its association with measures of ill-health in the Whitehall II study. Soc Sci Med. 2003;56(6):1321–33.
26.
Ludeke SG, Gensowski M, Junge SY, Kirkpatrick RM, John OP, Andersen SC. Does parental education influence child educational outcomes? A developmental analysis in a full-population sample and adoptee design. J Pers Soc Psychol. 2021;120(4):1074–90.
27.
Organisation for Economic Co-operation and Development. How does education affect employment rates?2012.
28.
Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002;31(2):285–93.
29.
Naik HB, Paul M, Cohen SR, Alavi A, Suàrez-Fariñas M, Lowes MA. Distribution of self-reported hidradenitis suppurativa age at onset. JAMA Dermatol. 2019;155(8):971–3.
30.
Vanlaerhoven AMJD, Ardon CB, van Straalen KR, Vossen ARJV, Prens EP, van der Zee HH. Hurley III hidradenitis suppurativa has an aggressive disease course. Dermatology. 2018;234(5–6):232–3.
31.
Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M. Psoriasis: is the impairment to a patient’s life cumulative?J Eur Acad Dermatol Venereol. 2010;24(9):989–1004.
32.
Bhatti ZU, Salek MS, Finlay AY. Major life changing decisions and cumulative life course impairment. J Eur Acad Dermatol Venereol. 2011;25(2):245–6; author reply 6.
33.
Prens LM, Bouwman K, Troelstra LD, Prens EP, Alizadeh BZ, Horváth B. New insights in hidradenitis suppurativa from a population-based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities. Br J Dermatol. 2022;186(5):814–22.
34.
Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, et al. Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian hidradenitis suppurativa foundations. J Am Acad Dermatol. 2022;86(5):1092–101.
35.
Moritmore AM, Bullen A, McMeniman EK. The impact of hidradenitis suppurativa on quality of life is worse than inflammatory bowel disease and myocardial infarction. Australas J Dermatol. 2022;63(4):505–508.
36.
Vinding GR, Knudsen KM, Ellervik C, Olesen AB, Jemec GB. Self-reported skin morbidities and health-related quality of life: a population-based nested case-control study. Dermatology. 2014;228(3):261–8.
37.
Jørgensen AHR, Holm JG, Ghazanfar MN, Yao Y, Ring HC, Thomsen SF. Factors affecting quality of life in patients with hidradenitis suppurativa. Arch Dermatol Res. 2020;312(6):427–36.
38.
Gergely LH, Gáspár K, Brodszky V, Kinyó Á, Szegedi A, Remenyik É, et al. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34(11):2584–92.
39.
Keary E, Hevey D, Tobin AM. A qualitative analysis of psychological distress in hidradenitis suppurativa. Br J Dermatol. 2020;182(2):342–7.
40.
Howells L, Lancaster N, McPhee M, Bundy C, Ingram JR, Leighton P, et al. Thematic synthesis of the experiences of people with hidradenitis suppurativa: a systematic review. Br J Dermatol. 2021;185(5):921–34.
41.
Kirby JS, Sisic M, Tan J. Exploring coping strategies for patients with hidradenitis suppurativa. JAMA Dermatol. 2016;152(10):1166–7.
42.
Kirby JS, Butt M, Esmann S, Jemec GBE. Association of resilience with depression and health-related quality of life for patients with hidradenitis suppurativa. JAMA Dermatol. 2017;153(12):1263–9.
You do not currently have access to this content.